Hantavirus: Silent Fever or Deadly Threat?

Hantavirus infection, transmitted primarily through infected rodent droppings or saliva, presents a rare but potentially severe health threat. Initial symptoms, which typically appear two to three weeks after exposure, commonly resemble a common viral fever, including fatigue, fever, and stomach discomfort. This can lead to delayed diagnosis as the illness may not initially appear dangerous.

However, the condition can rapidly escalate into a life-threatening scenario. Some patients may experience sudden deterioration within hours, developing severe breathing difficulties and low blood pressure, leading to a condition known as cardiopulmonary syndrome. While some strains are milder, others, like the Sin Nombre and Andes viruses, can lead to severe lung complications in a significant percentage of cases.

Beyond respiratory issues, hantavirus can also affect the kidneys, particularly with European and Asian strains, potentially requiring dialysis in severe instances. Currently, there is no specific cure; treatment focuses on supportive care, managing breathing and blood pressure, and aiding organ function. Early intervention and hospital care are vital for improving recovery outcomes and mitigating the risk of fatal complications.